Cross Country Healthcare Sets July 16 Shareholder Vote for $437M Knox Lane Merger; Addresses Lawsuits
CCRN sits 78% above its 52-week low of $7.43.
Summary
Cross Country Healthcare has scheduled a special shareholder meeting for July 16 to vote on its $437 million all-cash merger with Knox Lane. This follows the May 6th announcement of the acquisition and the June 23rd expiration of the HSR waiting period. The company also filed supplemental proxy disclosures to address shareholder lawsuits alleging deficiencies, which it denies. The shareholder vote is a critical final step for the merger, which is expected to close in Q3 2026. Traders will watch the July 16th vote closely.
At the time of this announcement, CCRN was trading at $13.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $426.4M. The 52-week trading range was $7.43 to $14.99. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.